nodes	percent_of_prediction	percent_of_DWPC	metapath
Fulvestrant—ESR2—coronary artery disease	0.297	0.619	CbGaD
Fulvestrant—ESR1—coronary artery disease	0.183	0.381	CbGaD
Fulvestrant—CYP3A4—Ticagrelor—coronary artery disease	0.0271	0.146	CbGbCtD
Fulvestrant—CYP3A4—Fenofibrate—coronary artery disease	0.0242	0.131	CbGbCtD
Fulvestrant—CYP3A4—Gemfibrozil—coronary artery disease	0.0193	0.104	CbGbCtD
Fulvestrant—CYP3A4—Clopidogrel—coronary artery disease	0.0168	0.0905	CbGbCtD
Fulvestrant—CYP3A4—Eplerenone—coronary artery disease	0.0156	0.0841	CbGbCtD
Fulvestrant—CYP3A4—Enalapril—coronary artery disease	0.0139	0.075	CbGbCtD
Fulvestrant—CYP3A4—Ezetimibe—coronary artery disease	0.0108	0.0583	CbGbCtD
Fulvestrant—CYP3A4—Rosuvastatin—coronary artery disease	0.0108	0.0583	CbGbCtD
Fulvestrant—CYP3A4—Simvastatin—coronary artery disease	0.01	0.0542	CbGbCtD
Fulvestrant—CYP3A4—Lovastatin—coronary artery disease	0.00982	0.053	CbGbCtD
Fulvestrant—CYP3A4—Pravastatin—coronary artery disease	0.00982	0.053	CbGbCtD
Fulvestrant—CYP3A4—Atorvastatin—coronary artery disease	0.00895	0.0483	CbGbCtD
Fulvestrant—CYP3A4—Losartan—coronary artery disease	0.00818	0.0442	CbGbCtD
Fulvestrant—ESRRA—cardiac ventricle—coronary artery disease	0.00154	0.121	CbGeAlD
Fulvestrant—ESRRA—myocardium—coronary artery disease	0.00145	0.114	CbGeAlD
Fulvestrant—NR1H4—cardiovascular system—coronary artery disease	0.00125	0.0977	CbGeAlD
Fulvestrant—EPHX2—heart—coronary artery disease	0.00116	0.0905	CbGeAlD
Fulvestrant—ESRRA—heart—coronary artery disease	0.00101	0.0792	CbGeAlD
Fulvestrant—ESRRA—cardiovascular system—coronary artery disease	0.000957	0.0748	CbGeAlD
Fulvestrant—ESRRA—cardiac atrium—coronary artery disease	0.000867	0.0678	CbGeAlD
Fulvestrant—EPHX2—blood—coronary artery disease	0.000864	0.0675	CbGeAlD
Fulvestrant—ESRRA—blood—coronary artery disease	0.000757	0.0591	CbGeAlD
Fulvestrant—Estradiol—SLC22A3—coronary artery disease	0.000737	0.345	CrCbGaD
Fulvestrant—ESR2—heart—coronary artery disease	0.000608	0.0476	CbGeAlD
Fulvestrant—Estradiol—ESR2—coronary artery disease	0.000587	0.275	CrCbGaD
Fulvestrant—ESR2—cardiovascular system—coronary artery disease	0.000574	0.0449	CbGeAlD
Fulvestrant—ESR2—blood—coronary artery disease	0.000454	0.0355	CbGeAlD
Fulvestrant—ESR1—heart—coronary artery disease	0.000417	0.0326	CbGeAlD
Fulvestrant—ESR1—cardiovascular system—coronary artery disease	0.000393	0.0307	CbGeAlD
Fulvestrant—Estradiol—ESR1—coronary artery disease	0.000362	0.169	CrCbGaD
Fulvestrant—ESR1—blood—coronary artery disease	0.000311	0.0243	CbGeAlD
Fulvestrant—Estradiol—CYP2C19—coronary artery disease	0.00029	0.136	CrCbGaD
Fulvestrant—CYP3A4—blood—coronary artery disease	0.000174	0.0136	CbGeAlD
Fulvestrant—Estradiol—ALB—coronary artery disease	0.000161	0.0754	CrCbGaD
Fulvestrant—Unspecified disorder of skin and subcutaneous tissue—Ramipril—coronary artery disease	9.79e-05	0.000518	CcSEcCtD
Fulvestrant—Dermatitis—Clopidogrel—coronary artery disease	9.78e-05	0.000517	CcSEcCtD
Fulvestrant—Asthenia—Valsartan—coronary artery disease	9.78e-05	0.000517	CcSEcCtD
Fulvestrant—Pain—Furosemide—coronary artery disease	9.77e-05	0.000517	CcSEcCtD
Fulvestrant—Constipation—Furosemide—coronary artery disease	9.77e-05	0.000517	CcSEcCtD
Fulvestrant—Hypersensitivity—Niacin—coronary artery disease	9.76e-05	0.000516	CcSEcCtD
Fulvestrant—Asthenia—Olmesartan—coronary artery disease	9.73e-05	0.000515	CcSEcCtD
Fulvestrant—Headache—Clopidogrel—coronary artery disease	9.73e-05	0.000515	CcSEcCtD
Fulvestrant—Rash—Lovastatin—coronary artery disease	9.73e-05	0.000515	CcSEcCtD
Fulvestrant—Dermatitis—Lovastatin—coronary artery disease	9.72e-05	0.000514	CcSEcCtD
Fulvestrant—Anaemia—Lisinopril—coronary artery disease	9.7e-05	0.000513	CcSEcCtD
Fulvestrant—Dyspepsia—Losartan—coronary artery disease	9.7e-05	0.000513	CcSEcCtD
Fulvestrant—Headache—Lovastatin—coronary artery disease	9.66e-05	0.000511	CcSEcCtD
Fulvestrant—Pruritus—Valsartan—coronary artery disease	9.64e-05	0.00051	CcSEcCtD
Fulvestrant—Chest pain—Timolol—coronary artery disease	9.64e-05	0.00051	CcSEcCtD
Fulvestrant—Arthralgia—Timolol—coronary artery disease	9.64e-05	0.00051	CcSEcCtD
Fulvestrant—Myalgia—Timolol—coronary artery disease	9.64e-05	0.00051	CcSEcCtD
Fulvestrant—Vomiting—Ezetimibe—coronary artery disease	9.62e-05	0.000509	CcSEcCtD
Fulvestrant—Hypersensitivity—Pravastatin—coronary artery disease	9.61e-05	0.000508	CcSEcCtD
Fulvestrant—Gastrointestinal pain—Perindopril—coronary artery disease	9.61e-05	0.000508	CcSEcCtD
Fulvestrant—Anxiety—Timolol—coronary artery disease	9.6e-05	0.000508	CcSEcCtD
Fulvestrant—Angioedema—Lisinopril—coronary artery disease	9.59e-05	0.000508	CcSEcCtD
Fulvestrant—Pruritus—Olmesartan—coronary artery disease	9.59e-05	0.000508	CcSEcCtD
Fulvestrant—Decreased appetite—Losartan—coronary artery disease	9.58e-05	0.000507	CcSEcCtD
Fulvestrant—Unspecified disorder of skin and subcutaneous tissue—Timolol—coronary artery disease	9.57e-05	0.000506	CcSEcCtD
Fulvestrant—Abdominal pain—Captopril—coronary artery disease	9.56e-05	0.000506	CcSEcCtD
Fulvestrant—Body temperature increased—Captopril—coronary artery disease	9.56e-05	0.000506	CcSEcCtD
Fulvestrant—Dizziness—Simvastatin—coronary artery disease	9.54e-05	0.000505	CcSEcCtD
Fulvestrant—Rash—Ezetimibe—coronary artery disease	9.54e-05	0.000505	CcSEcCtD
Fulvestrant—Dermatitis—Ezetimibe—coronary artery disease	9.53e-05	0.000504	CcSEcCtD
Fulvestrant—Asthenia—Niacin—coronary artery disease	9.5e-05	0.000503	CcSEcCtD
Fulvestrant—Fatigue—Losartan—coronary artery disease	9.5e-05	0.000503	CcSEcCtD
Fulvestrant—Headache—Ezetimibe—coronary artery disease	9.48e-05	0.000501	CcSEcCtD
Fulvestrant—Vertigo—Lisinopril—coronary artery disease	9.43e-05	0.000499	CcSEcCtD
Fulvestrant—Pain—Losartan—coronary artery disease	9.42e-05	0.000499	CcSEcCtD
Fulvestrant—Constipation—Losartan—coronary artery disease	9.42e-05	0.000499	CcSEcCtD
Fulvestrant—Vomiting—Eplerenone—coronary artery disease	9.41e-05	0.000498	CcSEcCtD
Fulvestrant—Leukopenia—Lisinopril—coronary artery disease	9.4e-05	0.000497	CcSEcCtD
Fulvestrant—Nausea—Fenofibrate—coronary artery disease	9.38e-05	0.000496	CcSEcCtD
Fulvestrant—Pruritus—Niacin—coronary artery disease	9.37e-05	0.000496	CcSEcCtD
Fulvestrant—Asthenia—Pravastatin—coronary artery disease	9.36e-05	0.000495	CcSEcCtD
Fulvestrant—Gastrointestinal pain—Furosemide—coronary artery disease	9.34e-05	0.000494	CcSEcCtD
Fulvestrant—Rash—Eplerenone—coronary artery disease	9.34e-05	0.000494	CcSEcCtD
Fulvestrant—Urticaria—Perindopril—coronary artery disease	9.33e-05	0.000494	CcSEcCtD
Fulvestrant—Hypersensitivity—Trandolapril—coronary artery disease	9.33e-05	0.000494	CcSEcCtD
Fulvestrant—Dermatitis—Eplerenone—coronary artery disease	9.33e-05	0.000493	CcSEcCtD
Fulvestrant—Diarrhoea—Valsartan—coronary artery disease	9.32e-05	0.000493	CcSEcCtD
Fulvestrant—Hypersensitivity—Enalapril—coronary artery disease	9.29e-05	0.000492	CcSEcCtD
Fulvestrant—Abdominal pain—Perindopril—coronary artery disease	9.29e-05	0.000491	CcSEcCtD
Fulvestrant—Body temperature increased—Perindopril—coronary artery disease	9.29e-05	0.000491	CcSEcCtD
Fulvestrant—Diarrhoea—Olmesartan—coronary artery disease	9.28e-05	0.000491	CcSEcCtD
Fulvestrant—Headache—Eplerenone—coronary artery disease	9.28e-05	0.000491	CcSEcCtD
Fulvestrant—Nervous system disorder—Ramipril—coronary artery disease	9.27e-05	0.00049	CcSEcCtD
Fulvestrant—Pruritus—Pravastatin—coronary artery disease	9.23e-05	0.000488	CcSEcCtD
Fulvestrant—Nausea—Clopidogrel—coronary artery disease	9.22e-05	0.000488	CcSEcCtD
Fulvestrant—Skin disorder—Ramipril—coronary artery disease	9.18e-05	0.000486	CcSEcCtD
Fulvestrant—Infection—Timolol—coronary artery disease	9.18e-05	0.000485	CcSEcCtD
Fulvestrant—Vomiting—Simvastatin—coronary artery disease	9.17e-05	0.000485	CcSEcCtD
Fulvestrant—Hypersensitivity—Telmisartan—coronary artery disease	9.17e-05	0.000485	CcSEcCtD
Fulvestrant—Cough—Lisinopril—coronary artery disease	9.16e-05	0.000485	CcSEcCtD
Fulvestrant—Nausea—Lovastatin—coronary artery disease	9.16e-05	0.000485	CcSEcCtD
Fulvestrant—Hyperhidrosis—Ramipril—coronary artery disease	9.13e-05	0.000483	CcSEcCtD
Fulvestrant—Rash—Simvastatin—coronary artery disease	9.1e-05	0.000481	CcSEcCtD
Fulvestrant—Dermatitis—Simvastatin—coronary artery disease	9.09e-05	0.000481	CcSEcCtD
Fulvestrant—Asthenia—Trandolapril—coronary artery disease	9.09e-05	0.000481	CcSEcCtD
Fulvestrant—Urticaria—Furosemide—coronary artery disease	9.07e-05	0.00048	CcSEcCtD
Fulvestrant—Diarrhoea—Niacin—coronary artery disease	9.06e-05	0.00048	CcSEcCtD
Fulvestrant—Nervous system disorder—Timolol—coronary artery disease	9.06e-05	0.000479	CcSEcCtD
Fulvestrant—Asthenia—Enalapril—coronary artery disease	9.05e-05	0.000479	CcSEcCtD
Fulvestrant—Headache—Simvastatin—coronary artery disease	9.04e-05	0.000478	CcSEcCtD
Fulvestrant—Body temperature increased—Furosemide—coronary artery disease	9.03e-05	0.000478	CcSEcCtD
Fulvestrant—Abdominal pain—Furosemide—coronary artery disease	9.03e-05	0.000478	CcSEcCtD
Fulvestrant—Gastrointestinal pain—Losartan—coronary artery disease	9.01e-05	0.000477	CcSEcCtD
Fulvestrant—Dizziness—Valsartan—coronary artery disease	9.01e-05	0.000477	CcSEcCtD
Fulvestrant—Anorexia—Ramipril—coronary artery disease	9.01e-05	0.000476	CcSEcCtD
Fulvestrant—Nausea—Ezetimibe—coronary artery disease	8.99e-05	0.000475	CcSEcCtD
Fulvestrant—Skin disorder—Timolol—coronary artery disease	8.97e-05	0.000475	CcSEcCtD
Fulvestrant—Dizziness—Olmesartan—coronary artery disease	8.97e-05	0.000474	CcSEcCtD
Fulvestrant—Pruritus—Trandolapril—coronary artery disease	8.96e-05	0.000474	CcSEcCtD
Fulvestrant—Myalgia—Lisinopril—coronary artery disease	8.94e-05	0.000473	CcSEcCtD
Fulvestrant—Chest pain—Lisinopril—coronary artery disease	8.94e-05	0.000473	CcSEcCtD
Fulvestrant—Arthralgia—Lisinopril—coronary artery disease	8.94e-05	0.000473	CcSEcCtD
Fulvestrant—Hyperhidrosis—Timolol—coronary artery disease	8.93e-05	0.000472	CcSEcCtD
Fulvestrant—Asthenia—Telmisartan—coronary artery disease	8.93e-05	0.000472	CcSEcCtD
Fulvestrant—Pruritus—Enalapril—coronary artery disease	8.93e-05	0.000472	CcSEcCtD
Fulvestrant—Diarrhoea—Pravastatin—coronary artery disease	8.92e-05	0.000472	CcSEcCtD
Fulvestrant—Anxiety—Lisinopril—coronary artery disease	8.91e-05	0.000471	CcSEcCtD
Fulvestrant—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—coronary artery disease	8.88e-05	0.00047	CcSEcCtD
Fulvestrant—Anorexia—Timolol—coronary artery disease	8.8e-05	0.000466	CcSEcCtD
Fulvestrant—Pruritus—Telmisartan—coronary artery disease	8.8e-05	0.000466	CcSEcCtD
Fulvestrant—Nausea—Eplerenone—coronary artery disease	8.8e-05	0.000465	CcSEcCtD
Fulvestrant—Dizziness—Niacin—coronary artery disease	8.76e-05	0.000463	CcSEcCtD
Fulvestrant—Urticaria—Losartan—coronary artery disease	8.75e-05	0.000463	CcSEcCtD
Fulvestrant—Abdominal pain—Losartan—coronary artery disease	8.71e-05	0.000461	CcSEcCtD
Fulvestrant—Body temperature increased—Losartan—coronary artery disease	8.71e-05	0.000461	CcSEcCtD
Fulvestrant—Asthenia—Captopril—coronary artery disease	8.68e-05	0.000459	CcSEcCtD
Fulvestrant—Diarrhoea—Trandolapril—coronary artery disease	8.67e-05	0.000459	CcSEcCtD
Fulvestrant—Vomiting—Valsartan—coronary artery disease	8.66e-05	0.000458	CcSEcCtD
Fulvestrant—Diarrhoea—Enalapril—coronary artery disease	8.63e-05	0.000457	CcSEcCtD
Fulvestrant—Dizziness—Pravastatin—coronary artery disease	8.63e-05	0.000456	CcSEcCtD
Fulvestrant—Vomiting—Olmesartan—coronary artery disease	8.62e-05	0.000456	CcSEcCtD
Fulvestrant—Musculoskeletal discomfort—Ramipril—coronary artery disease	8.61e-05	0.000455	CcSEcCtD
Fulvestrant—Rash—Valsartan—coronary artery disease	8.59e-05	0.000454	CcSEcCtD
Fulvestrant—Dermatitis—Valsartan—coronary artery disease	8.58e-05	0.000454	CcSEcCtD
Fulvestrant—Nausea—Simvastatin—coronary artery disease	8.57e-05	0.000453	CcSEcCtD
Fulvestrant—Pruritus—Captopril—coronary artery disease	8.56e-05	0.000453	CcSEcCtD
Fulvestrant—Rash—Olmesartan—coronary artery disease	8.55e-05	0.000452	CcSEcCtD
Fulvestrant—Insomnia—Ramipril—coronary artery disease	8.55e-05	0.000452	CcSEcCtD
Fulvestrant—Dermatitis—Olmesartan—coronary artery disease	8.54e-05	0.000452	CcSEcCtD
Fulvestrant—Headache—Valsartan—coronary artery disease	8.54e-05	0.000452	CcSEcCtD
Fulvestrant—Diarrhoea—Telmisartan—coronary artery disease	8.51e-05	0.00045	CcSEcCtD
Fulvestrant—Infection—Lisinopril—coronary artery disease	8.51e-05	0.00045	CcSEcCtD
Fulvestrant—Headache—Olmesartan—coronary artery disease	8.49e-05	0.000449	CcSEcCtD
Fulvestrant—Paraesthesia—Ramipril—coronary artery disease	8.48e-05	0.000449	CcSEcCtD
Fulvestrant—Asthenia—Perindopril—coronary artery disease	8.43e-05	0.000446	CcSEcCtD
Fulvestrant—Dyspnoea—Ramipril—coronary artery disease	8.42e-05	0.000446	CcSEcCtD
Fulvestrant—Vomiting—Niacin—coronary artery disease	8.42e-05	0.000446	CcSEcCtD
Fulvestrant—Musculoskeletal discomfort—Timolol—coronary artery disease	8.42e-05	0.000445	CcSEcCtD
Fulvestrant—Hypersensitivity—Furosemide—coronary artery disease	8.41e-05	0.000445	CcSEcCtD
Fulvestrant—Dizziness—Trandolapril—coronary artery disease	8.38e-05	0.000443	CcSEcCtD
Fulvestrant—Insomnia—Timolol—coronary artery disease	8.35e-05	0.000442	CcSEcCtD
Fulvestrant—Rash—Niacin—coronary artery disease	8.35e-05	0.000442	CcSEcCtD
Fulvestrant—Dermatitis—Niacin—coronary artery disease	8.34e-05	0.000441	CcSEcCtD
Fulvestrant—Dizziness—Enalapril—coronary artery disease	8.34e-05	0.000441	CcSEcCtD
Fulvestrant—Skin disorder—Lisinopril—coronary artery disease	8.32e-05	0.00044	CcSEcCtD
Fulvestrant—Dyspepsia—Ramipril—coronary artery disease	8.32e-05	0.00044	CcSEcCtD
Fulvestrant—Pruritus—Perindopril—coronary artery disease	8.31e-05	0.00044	CcSEcCtD
Fulvestrant—Headache—Niacin—coronary artery disease	8.3e-05	0.000439	CcSEcCtD
Fulvestrant—Paraesthesia—Timolol—coronary artery disease	8.29e-05	0.000439	CcSEcCtD
Fulvestrant—Vomiting—Pravastatin—coronary artery disease	8.29e-05	0.000439	CcSEcCtD
Fulvestrant—Hyperhidrosis—Lisinopril—coronary artery disease	8.28e-05	0.000438	CcSEcCtD
Fulvestrant—Diarrhoea—Captopril—coronary artery disease	8.28e-05	0.000438	CcSEcCtD
Fulvestrant—Dyspnoea—Timolol—coronary artery disease	8.23e-05	0.000436	CcSEcCtD
Fulvestrant—Dizziness—Telmisartan—coronary artery disease	8.23e-05	0.000435	CcSEcCtD
Fulvestrant—Rash—Pravastatin—coronary artery disease	8.22e-05	0.000435	CcSEcCtD
Fulvestrant—Dermatitis—Pravastatin—coronary artery disease	8.22e-05	0.000435	CcSEcCtD
Fulvestrant—Decreased appetite—Ramipril—coronary artery disease	8.21e-05	0.000435	CcSEcCtD
Fulvestrant—Asthenia—Furosemide—coronary artery disease	8.19e-05	0.000434	CcSEcCtD
Fulvestrant—Headache—Pravastatin—coronary artery disease	8.17e-05	0.000432	CcSEcCtD
Fulvestrant—Anorexia—Lisinopril—coronary artery disease	8.17e-05	0.000432	CcSEcCtD
Fulvestrant—Gastrointestinal disorder—Ramipril—coronary artery disease	8.16e-05	0.000432	CcSEcCtD
Fulvestrant—Fatigue—Ramipril—coronary artery disease	8.15e-05	0.000431	CcSEcCtD
Fulvestrant—Dyspepsia—Timolol—coronary artery disease	8.13e-05	0.00043	CcSEcCtD
Fulvestrant—Hypersensitivity—Losartan—coronary artery disease	8.12e-05	0.00043	CcSEcCtD
Fulvestrant—Nausea—Valsartan—coronary artery disease	8.09e-05	0.000428	CcSEcCtD
Fulvestrant—Pruritus—Furosemide—coronary artery disease	8.08e-05	0.000427	CcSEcCtD
Fulvestrant—Constipation—Ramipril—coronary artery disease	8.08e-05	0.000427	CcSEcCtD
Fulvestrant—Nausea—Olmesartan—coronary artery disease	8.05e-05	0.000426	CcSEcCtD
Fulvestrant—Vomiting—Trandolapril—coronary artery disease	8.05e-05	0.000426	CcSEcCtD
Fulvestrant—Diarrhoea—Perindopril—coronary artery disease	8.04e-05	0.000425	CcSEcCtD
Fulvestrant—Decreased appetite—Timolol—coronary artery disease	8.03e-05	0.000425	CcSEcCtD
Fulvestrant—Vomiting—Enalapril—coronary artery disease	8.02e-05	0.000424	CcSEcCtD
Fulvestrant—Dizziness—Captopril—coronary artery disease	8e-05	0.000423	CcSEcCtD
Fulvestrant—Rash—Trandolapril—coronary artery disease	7.99e-05	0.000423	CcSEcCtD
Fulvestrant—Dermatitis—Trandolapril—coronary artery disease	7.98e-05	0.000422	CcSEcCtD
Fulvestrant—Gastrointestinal disorder—Timolol—coronary artery disease	7.97e-05	0.000422	CcSEcCtD
Fulvestrant—Fatigue—Timolol—coronary artery disease	7.96e-05	0.000421	CcSEcCtD
Fulvestrant—Rash—Enalapril—coronary artery disease	7.95e-05	0.000421	CcSEcCtD
Fulvestrant—Dermatitis—Enalapril—coronary artery disease	7.95e-05	0.00042	CcSEcCtD
Fulvestrant—Headache—Trandolapril—coronary artery disease	7.93e-05	0.00042	CcSEcCtD
Fulvestrant—Vomiting—Telmisartan—coronary artery disease	7.91e-05	0.000419	CcSEcCtD
Fulvestrant—Asthenia—Losartan—coronary artery disease	7.91e-05	0.000418	CcSEcCtD
Fulvestrant—Headache—Enalapril—coronary artery disease	7.9e-05	0.000418	CcSEcCtD
Fulvestrant—Pain—Timolol—coronary artery disease	7.9e-05	0.000418	CcSEcCtD
Fulvestrant—Nausea—Niacin—coronary artery disease	7.87e-05	0.000416	CcSEcCtD
Fulvestrant—Rash—Telmisartan—coronary artery disease	7.85e-05	0.000415	CcSEcCtD
Fulvestrant—Dermatitis—Telmisartan—coronary artery disease	7.84e-05	0.000415	CcSEcCtD
Fulvestrant—Diarrhoea—Furosemide—coronary artery disease	7.81e-05	0.000413	CcSEcCtD
Fulvestrant—Musculoskeletal discomfort—Lisinopril—coronary artery disease	7.81e-05	0.000413	CcSEcCtD
Fulvestrant—Pruritus—Losartan—coronary artery disease	7.8e-05	0.000412	CcSEcCtD
Fulvestrant—Headache—Telmisartan—coronary artery disease	7.79e-05	0.000412	CcSEcCtD
Fulvestrant—Dizziness—Perindopril—coronary artery disease	7.77e-05	0.000411	CcSEcCtD
Fulvestrant—Insomnia—Lisinopril—coronary artery disease	7.75e-05	0.00041	CcSEcCtD
Fulvestrant—Nausea—Pravastatin—coronary artery disease	7.75e-05	0.00041	CcSEcCtD
Fulvestrant—Gastrointestinal pain—Ramipril—coronary artery disease	7.73e-05	0.000409	CcSEcCtD
Fulvestrant—Paraesthesia—Lisinopril—coronary artery disease	7.69e-05	0.000407	CcSEcCtD
Fulvestrant—Vomiting—Captopril—coronary artery disease	7.69e-05	0.000407	CcSEcCtD
Fulvestrant—Dyspnoea—Lisinopril—coronary artery disease	7.64e-05	0.000404	CcSEcCtD
Fulvestrant—Rash—Captopril—coronary artery disease	7.63e-05	0.000404	CcSEcCtD
Fulvestrant—Dermatitis—Captopril—coronary artery disease	7.62e-05	0.000403	CcSEcCtD
Fulvestrant—Headache—Captopril—coronary artery disease	7.58e-05	0.000401	CcSEcCtD
Fulvestrant—Gastrointestinal pain—Timolol—coronary artery disease	7.55e-05	0.0004	CcSEcCtD
Fulvestrant—Dizziness—Furosemide—coronary artery disease	7.55e-05	0.0004	CcSEcCtD
Fulvestrant—Dyspepsia—Lisinopril—coronary artery disease	7.54e-05	0.000399	CcSEcCtD
Fulvestrant—Diarrhoea—Losartan—coronary artery disease	7.54e-05	0.000399	CcSEcCtD
Fulvestrant—Nausea—Trandolapril—coronary artery disease	7.52e-05	0.000398	CcSEcCtD
Fulvestrant—Urticaria—Ramipril—coronary artery disease	7.51e-05	0.000397	CcSEcCtD
Fulvestrant—Nausea—Enalapril—coronary artery disease	7.49e-05	0.000396	CcSEcCtD
Fulvestrant—Vomiting—Perindopril—coronary artery disease	7.47e-05	0.000395	CcSEcCtD
Fulvestrant—Abdominal pain—Ramipril—coronary artery disease	7.47e-05	0.000395	CcSEcCtD
Fulvestrant—Body temperature increased—Ramipril—coronary artery disease	7.47e-05	0.000395	CcSEcCtD
Fulvestrant—Decreased appetite—Lisinopril—coronary artery disease	7.45e-05	0.000394	CcSEcCtD
Fulvestrant—Rash—Perindopril—coronary artery disease	7.41e-05	0.000392	CcSEcCtD
Fulvestrant—Dermatitis—Perindopril—coronary artery disease	7.4e-05	0.000392	CcSEcCtD
Fulvestrant—Gastrointestinal disorder—Lisinopril—coronary artery disease	7.4e-05	0.000391	CcSEcCtD
Fulvestrant—Nausea—Telmisartan—coronary artery disease	7.39e-05	0.000391	CcSEcCtD
Fulvestrant—Fatigue—Lisinopril—coronary artery disease	7.39e-05	0.000391	CcSEcCtD
Fulvestrant—Headache—Perindopril—coronary artery disease	7.36e-05	0.000389	CcSEcCtD
Fulvestrant—Urticaria—Timolol—coronary artery disease	7.34e-05	0.000388	CcSEcCtD
Fulvestrant—Constipation—Lisinopril—coronary artery disease	7.33e-05	0.000388	CcSEcCtD
Fulvestrant—Pain—Lisinopril—coronary artery disease	7.33e-05	0.000388	CcSEcCtD
Fulvestrant—Body temperature increased—Timolol—coronary artery disease	7.3e-05	0.000386	CcSEcCtD
Fulvestrant—Abdominal pain—Timolol—coronary artery disease	7.3e-05	0.000386	CcSEcCtD
Fulvestrant—Dizziness—Losartan—coronary artery disease	7.29e-05	0.000386	CcSEcCtD
Fulvestrant—Vomiting—Furosemide—coronary artery disease	7.26e-05	0.000384	CcSEcCtD
Fulvestrant—Rash—Furosemide—coronary artery disease	7.2e-05	0.000381	CcSEcCtD
Fulvestrant—Dermatitis—Furosemide—coronary artery disease	7.19e-05	0.000381	CcSEcCtD
Fulvestrant—Nausea—Captopril—coronary artery disease	7.19e-05	0.00038	CcSEcCtD
Fulvestrant—Headache—Furosemide—coronary artery disease	7.15e-05	0.000379	CcSEcCtD
Fulvestrant—Gastrointestinal pain—Lisinopril—coronary artery disease	7.01e-05	0.000371	CcSEcCtD
Fulvestrant—Vomiting—Losartan—coronary artery disease	7.01e-05	0.000371	CcSEcCtD
Fulvestrant—Nausea—Perindopril—coronary artery disease	6.98e-05	0.000369	CcSEcCtD
Fulvestrant—Hypersensitivity—Ramipril—coronary artery disease	6.96e-05	0.000368	CcSEcCtD
Fulvestrant—Rash—Losartan—coronary artery disease	6.95e-05	0.000368	CcSEcCtD
Fulvestrant—Dermatitis—Losartan—coronary artery disease	6.94e-05	0.000367	CcSEcCtD
Fulvestrant—Headache—Losartan—coronary artery disease	6.9e-05	0.000365	CcSEcCtD
Fulvestrant—Urticaria—Lisinopril—coronary artery disease	6.81e-05	0.00036	CcSEcCtD
Fulvestrant—Hypersensitivity—Timolol—coronary artery disease	6.81e-05	0.00036	CcSEcCtD
Fulvestrant—Nausea—Furosemide—coronary artery disease	6.78e-05	0.000359	CcSEcCtD
Fulvestrant—Asthenia—Ramipril—coronary artery disease	6.78e-05	0.000359	CcSEcCtD
Fulvestrant—Abdominal pain—Lisinopril—coronary artery disease	6.77e-05	0.000358	CcSEcCtD
Fulvestrant—Body temperature increased—Lisinopril—coronary artery disease	6.77e-05	0.000358	CcSEcCtD
Fulvestrant—Pruritus—Ramipril—coronary artery disease	6.68e-05	0.000354	CcSEcCtD
Fulvestrant—Asthenia—Timolol—coronary artery disease	6.63e-05	0.000351	CcSEcCtD
Fulvestrant—Nausea—Losartan—coronary artery disease	6.55e-05	0.000346	CcSEcCtD
Fulvestrant—Pruritus—Timolol—coronary artery disease	6.53e-05	0.000346	CcSEcCtD
Fulvestrant—Diarrhoea—Ramipril—coronary artery disease	6.46e-05	0.000342	CcSEcCtD
Fulvestrant—Diarrhoea—Timolol—coronary artery disease	6.32e-05	0.000334	CcSEcCtD
Fulvestrant—Hypersensitivity—Lisinopril—coronary artery disease	6.31e-05	0.000334	CcSEcCtD
Fulvestrant—Dizziness—Ramipril—coronary artery disease	6.25e-05	0.000331	CcSEcCtD
Fulvestrant—Asthenia—Lisinopril—coronary artery disease	6.15e-05	0.000325	CcSEcCtD
Fulvestrant—Dizziness—Timolol—coronary artery disease	6.11e-05	0.000323	CcSEcCtD
Fulvestrant—Pruritus—Lisinopril—coronary artery disease	6.06e-05	0.000321	CcSEcCtD
Fulvestrant—Vomiting—Ramipril—coronary artery disease	6.01e-05	0.000318	CcSEcCtD
Fulvestrant—Rash—Ramipril—coronary artery disease	5.96e-05	0.000315	CcSEcCtD
Fulvestrant—Dermatitis—Ramipril—coronary artery disease	5.95e-05	0.000315	CcSEcCtD
Fulvestrant—Headache—Ramipril—coronary artery disease	5.92e-05	0.000313	CcSEcCtD
Fulvestrant—Vomiting—Timolol—coronary artery disease	5.87e-05	0.000311	CcSEcCtD
Fulvestrant—Diarrhoea—Lisinopril—coronary artery disease	5.86e-05	0.00031	CcSEcCtD
Fulvestrant—Rash—Timolol—coronary artery disease	5.82e-05	0.000308	CcSEcCtD
Fulvestrant—Dermatitis—Timolol—coronary artery disease	5.82e-05	0.000308	CcSEcCtD
Fulvestrant—Headache—Timolol—coronary artery disease	5.79e-05	0.000306	CcSEcCtD
Fulvestrant—Dizziness—Lisinopril—coronary artery disease	5.67e-05	0.0003	CcSEcCtD
Fulvestrant—Nausea—Ramipril—coronary artery disease	5.61e-05	0.000297	CcSEcCtD
Fulvestrant—Nausea—Timolol—coronary artery disease	5.49e-05	0.00029	CcSEcCtD
Fulvestrant—Vomiting—Lisinopril—coronary artery disease	5.45e-05	0.000288	CcSEcCtD
Fulvestrant—Rash—Lisinopril—coronary artery disease	5.4e-05	0.000286	CcSEcCtD
Fulvestrant—Dermatitis—Lisinopril—coronary artery disease	5.4e-05	0.000286	CcSEcCtD
Fulvestrant—Headache—Lisinopril—coronary artery disease	5.37e-05	0.000284	CcSEcCtD
Fulvestrant—Nausea—Lisinopril—coronary artery disease	5.09e-05	0.000269	CcSEcCtD
Fulvestrant—ESR1—Signaling Pathways—CCL4—coronary artery disease	1.16e-05	8.92e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—OPRD1—coronary artery disease	1.16e-05	8.92e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—GHR—coronary artery disease	1.16e-05	8.92e-05	CbGpPWpGaD
Fulvestrant—NR1H4—Gene Expression—SERPINE1—coronary artery disease	1.16e-05	8.88e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metapathway biotransformation—GSTM1—coronary artery disease	1.15e-05	8.83e-05	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—APOE—coronary artery disease	1.15e-05	8.8e-05	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—PIK3CA—coronary artery disease	1.14e-05	8.76e-05	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—PSMA6—coronary artery disease	1.14e-05	8.76e-05	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—PSMB5—coronary artery disease	1.14e-05	8.76e-05	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—APOA1—coronary artery disease	1.13e-05	8.7e-05	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Breast Cancer Pathway—AKT1—coronary artery disease	1.13e-05	8.64e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling by ERBB4—AKT1—coronary artery disease	1.12e-05	8.59e-05	CbGpPWpGaD
Fulvestrant—ESR2—Gene Expression—PPARG—coronary artery disease	1.12e-05	8.59e-05	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—CTGF—coronary artery disease	1.11e-05	8.56e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—TLE4—coronary artery disease	1.11e-05	8.56e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—MEF2A—coronary artery disease	1.11e-05	8.56e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—CKMT1B—coronary artery disease	1.09e-05	8.38e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—APOA2—coronary artery disease	1.09e-05	8.34e-05	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism of lipids and lipoproteins—PIK3CA—coronary artery disease	1.09e-05	8.33e-05	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—PTGS2—coronary artery disease	1.07e-05	8.25e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—AVPR1A—coronary artery disease	1.07e-05	8.24e-05	CbGpPWpGaD
Fulvestrant—ESR1—Generic Transcription Pathway—SERPINE1—coronary artery disease	1.06e-05	8.1e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—UTS2—coronary artery disease	1.04e-05	7.95e-05	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—HSPA1A—coronary artery disease	1.02e-05	7.83e-05	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—ESR2—coronary artery disease	1.02e-05	7.83e-05	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—JUNB—coronary artery disease	1.02e-05	7.83e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—NR4A1—coronary artery disease	1.01e-05	7.78e-05	CbGpPWpGaD
Fulvestrant—ESR2—Gene Expression—SERPINE1—coronary artery disease	1.01e-05	7.74e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—PLCB3—coronary artery disease	1e-05	7.7e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—HDAC9—coronary artery disease	1e-05	7.7e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—P2RY12—coronary artery disease	1e-05	7.7e-05	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—PPARG—coronary artery disease	9.99e-06	7.67e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CX3CR1—coronary artery disease	9.93e-06	7.63e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CASR—coronary artery disease	9.93e-06	7.63e-05	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—POMC—coronary artery disease	9.85e-06	7.56e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—GNA12—coronary artery disease	9.74e-06	7.48e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CX3CL1—coronary artery disease	9.74e-06	7.48e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—BDKRB1—coronary artery disease	9.74e-06	7.48e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—P4HB—coronary artery disease	9.74e-06	7.48e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—PPP3R1—coronary artery disease	9.56e-06	7.34e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—ADM—coronary artery disease	9.47e-06	7.27e-05	CbGpPWpGaD
Fulvestrant—ESR1—Integrated Pancreatic Cancer Pathway—AKT1—coronary artery disease	9.32e-06	7.16e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—PDE4B—coronary artery disease	9.23e-06	7.09e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CYBB—coronary artery disease	9.23e-06	7.09e-05	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—ALB—coronary artery disease	8.98e-06	6.89e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—CKM—coronary artery disease	8.89e-06	6.83e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—PPAP2B—coronary artery disease	8.89e-06	6.83e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—UQCRFS1—coronary artery disease	8.89e-06	6.83e-05	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—NOS3—coronary artery disease	8.59e-06	6.59e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CCR3—coronary artery disease	8.44e-06	6.48e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CRK—coronary artery disease	8.33e-06	6.4e-05	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—PIK3CA—coronary artery disease	8.27e-06	6.35e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—ALDH6A1—coronary artery disease	8.27e-06	6.35e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—PDK4—coronary artery disease	8.27e-06	6.35e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—SULT4A1—coronary artery disease	8.27e-06	6.35e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—CKMT2—coronary artery disease	8.27e-06	6.35e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—PYGM—coronary artery disease	8.27e-06	6.35e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Biological oxidations—POMC—coronary artery disease	8.24e-06	6.33e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—SH2B3—coronary artery disease	8.23e-06	6.32e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—ATP2A2—coronary artery disease	8.23e-06	6.32e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—VWF—coronary artery disease	8.23e-06	6.32e-05	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—SIRT1—coronary artery disease	8.21e-06	6.3e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—APOC3—coronary artery disease	8.18e-06	6.28e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—LDLR—coronary artery disease	8.13e-06	6.24e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CXCL2—coronary artery disease	7.94e-06	6.1e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CCL3—coronary artery disease	7.94e-06	6.1e-05	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—PTGS2—coronary artery disease	7.86e-06	6.03e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—F2R—coronary artery disease	7.85e-06	6.03e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—SDC1—coronary artery disease	7.85e-06	6.03e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—FGB—coronary artery disease	7.68e-06	5.9e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—EDNRB—coronary artery disease	7.6e-06	5.84e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—THBS1—coronary artery disease	7.49e-06	5.75e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—PSMB5—coronary artery disease	7.42e-06	5.69e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—PSMA6—coronary artery disease	7.42e-06	5.69e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—LDHA—coronary artery disease	7.37e-06	5.66e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—PFKM—coronary artery disease	7.37e-06	5.66e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—GK—coronary artery disease	7.37e-06	5.66e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—HMGCS2—coronary artery disease	7.37e-06	5.66e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—GYG1—coronary artery disease	7.37e-06	5.66e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—GATM—coronary artery disease	7.37e-06	5.66e-05	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—PPP2CA—coronary artery disease	7.25e-06	5.56e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—EDNRA—coronary artery disease	7.18e-06	5.51e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CYBA—coronary artery disease	7.15e-06	5.49e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—ADRB1—coronary artery disease	7.15e-06	5.49e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—DUSP6—coronary artery disease	7.12e-06	5.46e-05	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—PRKCD—coronary artery disease	7.12e-06	5.46e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—GCH1—coronary artery disease	7.03e-06	5.4e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—AK1—coronary artery disease	7.03e-06	5.4e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—PLAT—coronary artery disease	7e-06	5.37e-05	CbGpPWpGaD
Fulvestrant—ESRRA—Gene Expression—AKT1—coronary artery disease	6.95e-06	5.33e-05	CbGpPWpGaD
Fulvestrant—EPHX2—Metabolism—AKT1—coronary artery disease	6.76e-06	5.19e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CXCL12—coronary artery disease	6.75e-06	5.18e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—BDKRB2—coronary artery disease	6.75e-06	5.18e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—UGCG—coronary artery disease	6.74e-06	5.18e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—MDH2—coronary artery disease	6.74e-06	5.18e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—PLCD1—coronary artery disease	6.74e-06	5.18e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—PPAT—coronary artery disease	6.74e-06	5.18e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—JUNB—coronary artery disease	6.63e-06	5.09e-05	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—PIK3CA—coronary artery disease	6.61e-06	5.08e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—PLCB1—coronary artery disease	6.6e-06	5.07e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—PGM1—coronary artery disease	6.49e-06	4.98e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—HTR7—coronary artery disease	6.46e-06	4.96e-05	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—MAPK14—coronary artery disease	6.3e-06	4.84e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—CKB—coronary artery disease	6.27e-06	4.81e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—PYGB—coronary artery disease	6.27e-06	4.81e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—ITGAV—coronary artery disease	6.16e-06	4.73e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—KNG1—coronary artery disease	6.14e-06	4.72e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—AGTR1—coronary artery disease	6.11e-06	4.69e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CXCL10—coronary artery disease	5.97e-06	4.58e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—PLG—coronary artery disease	5.95e-06	4.57e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—GSTM2—coronary artery disease	5.89e-06	4.52e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—DLAT—coronary artery disease	5.89e-06	4.52e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—COX5B—coronary artery disease	5.89e-06	4.52e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—PFKFB3—coronary artery disease	5.89e-06	4.52e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—PLIN1—coronary artery disease	5.89e-06	4.52e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—ADRB2—coronary artery disease	5.79e-06	4.45e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—PRKCE—coronary artery disease	5.72e-06	4.39e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—SOCS1—coronary artery disease	5.7e-06	4.38e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—S100B—coronary artery disease	5.69e-06	4.37e-05	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—PPARG—coronary artery disease	5.64e-06	4.33e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—SOCS3—coronary artery disease	5.63e-06	4.33e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—SULT1E1—coronary artery disease	5.59e-06	4.29e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—KITLG—coronary artery disease	5.57e-06	4.27e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—TGFBR2—coronary artery disease	5.57e-06	4.27e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—MMP3—coronary artery disease	5.44e-06	4.18e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—STAT5A—coronary artery disease	5.44e-06	4.18e-05	CbGpPWpGaD
Fulvestrant—ESRRA—Metabolism—AKT1—coronary artery disease	5.4e-06	4.15e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—AKR1B1—coronary artery disease	5.33e-06	4.09e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—HK2—coronary artery disease	5.33e-06	4.09e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—APOB—coronary artery disease	5.26e-06	4.04e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—EDN1—coronary artery disease	5.18e-06	3.97e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CCL5—coronary artery disease	5.14e-06	3.94e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—SLC27A1—coronary artery disease	5.11e-06	3.92e-05	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—SERPINE1—coronary artery disease	5.08e-06	3.9e-05	CbGpPWpGaD
Fulvestrant—NR1H4—Gene Expression—AKT1—coronary artery disease	5.08e-06	3.9e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CSF2—coronary artery disease	5.06e-06	3.88e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—FGF1—coronary artery disease	5.06e-06	3.88e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—LPL—coronary artery disease	5.02e-06	3.86e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—CPT1B—coronary artery disease	5.01e-06	3.85e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—LCAT—coronary artery disease	5.01e-06	3.85e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—RPS6KB1—coronary artery disease	4.98e-06	3.82e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—MEF2C—coronary artery disease	4.98e-06	3.82e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—APOA4—coronary artery disease	4.92e-06	3.78e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—ITGB3—coronary artery disease	4.85e-06	3.72e-05	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—PIK3CA—coronary artery disease	4.83e-06	3.71e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—GCLM—coronary artery disease	4.75e-06	3.65e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—PDHA1—coronary artery disease	4.75e-06	3.65e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—PPP2CA—coronary artery disease	4.71e-06	3.62e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—PRKCD—coronary artery disease	4.63e-06	3.55e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—TXNRD1—coronary artery disease	4.6e-06	3.53e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—CYP11B2—coronary artery disease	4.6e-06	3.53e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—SLC22A3—coronary artery disease	4.53e-06	3.48e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—HTR2A—coronary artery disease	4.53e-06	3.48e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—C3—coronary artery disease	4.52e-06	3.47e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—HADH—coronary artery disease	4.47e-06	3.43e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—ARNTL—coronary artery disease	4.47e-06	3.43e-05	CbGpPWpGaD
Fulvestrant—ESR2—Gene Expression—AKT1—coronary artery disease	4.42e-06	3.39e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—HIF1A—coronary artery disease	4.31e-06	3.31e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—AGT—coronary artery disease	4.3e-06	3.3e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—APOA2—coronary artery disease	4.23e-06	3.25e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—GPX2—coronary artery disease	4.23e-06	3.25e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—PLA2G2A—coronary artery disease	4.23e-06	3.25e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—LEP—coronary artery disease	4.21e-06	3.23e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—APOE—coronary artery disease	4.21e-06	3.23e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—HK1—coronary artery disease	4.18e-06	3.21e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—GPX4—coronary artery disease	4.18e-06	3.21e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—SULT1A1—coronary artery disease	4.18e-06	3.21e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—ABCG5—coronary artery disease	4.18e-06	3.21e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—APOA1—coronary artery disease	4.16e-06	3.19e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—HADHA—coronary artery disease	4.13e-06	3.17e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—KDR—coronary artery disease	4.12e-06	3.17e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—MAPK14—coronary artery disease	4.1e-06	3.15e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—GSTA1—coronary artery disease	4.08e-06	3.14e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—LPA—coronary artery disease	4.04e-06	3.1e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—FN1—coronary artery disease	3.97e-06	3.05e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—F2—coronary artery disease	3.97e-06	3.05e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—IL6ST—coronary artery disease	3.95e-06	3.04e-05	CbGpPWpGaD
Fulvestrant—NR1H4—Metabolism—AKT1—coronary artery disease	3.95e-06	3.03e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—NFKBIA—coronary artery disease	3.92e-06	3.01e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—PLCB3—coronary artery disease	3.91e-06	3e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—APOA5—coronary artery disease	3.87e-06	2.97e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—KIT—coronary artery disease	3.8e-06	2.92e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—P4HB—coronary artery disease	3.8e-06	2.92e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—PLA2G1B—coronary artery disease	3.73e-06	2.86e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—GSK3B—coronary artery disease	3.65e-06	2.8e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—POMC—coronary artery disease	3.62e-06	2.78e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CREB1—coronary artery disease	3.62e-06	2.78e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CCL2—coronary artery disease	3.54e-06	2.72e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—IL6R—coronary artery disease	3.53e-06	2.71e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—VCAN—coronary artery disease	3.51e-06	2.7e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—ALDOA—coronary artery disease	3.49e-06	2.68e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—IGF1—coronary artery disease	3.48e-06	2.67e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—DCN—coronary artery disease	3.38e-06	2.6e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—SERPINE1—coronary artery disease	3.3e-06	2.54e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—ALDH2—coronary artery disease	3.29e-06	2.53e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—CYP2C19—coronary artery disease	3.21e-06	2.46e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—PIK3C2A—coronary artery disease	3.21e-06	2.46e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—HBA1—coronary artery disease	3.21e-06	2.46e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—LIPC—coronary artery disease	3.21e-06	2.46e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—FGF2—coronary artery disease	3.2e-06	2.46e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—APOC3—coronary artery disease	3.19e-06	2.45e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—LDLR—coronary artery disease	3.17e-06	2.43e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—NOS3—coronary artery disease	3.15e-06	2.42e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—GSTT1—coronary artery disease	3.13e-06	2.4e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—SLC9A1—coronary artery disease	3.13e-06	2.4e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—CETP—coronary artery disease	3.1e-06	2.38e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—GCLC—coronary artery disease	3.1e-06	2.38e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—JAK2—coronary artery disease	3.06e-06	2.35e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—SDC1—coronary artery disease	3.06e-06	2.35e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—PSMB5—coronary artery disease	2.89e-06	2.22e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—PSMA6—coronary artery disease	2.89e-06	2.22e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—CTGF—coronary artery disease	2.82e-06	2.17e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—HMGCR—coronary artery disease	2.8e-06	2.15e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—GOT2—coronary artery disease	2.8e-06	2.15e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CXCL8—coronary artery disease	2.8e-06	2.15e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CASP3—coronary artery disease	2.68e-06	2.06e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—CCND1—coronary artery disease	2.61e-06	2e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—PLCB1—coronary artery disease	2.57e-06	1.98e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—MMP9—coronary artery disease	2.53e-06	1.94e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—ABCA1—coronary artery disease	2.49e-06	1.92e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—GGT1—coronary artery disease	2.42e-06	1.86e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—GOT1—coronary artery disease	2.42e-06	1.86e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—VEGFA—coronary artery disease	2.27e-06	1.74e-05	CbGpPWpGaD
Fulvestrant—ESR1—Gene Expression—AKT1—coronary artery disease	2.23e-06	1.71e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—GSTP1—coronary artery disease	2.17e-06	1.67e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—PPARGC1A—coronary artery disease	2.15e-06	1.65e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—HMOX1—coronary artery disease	2.14e-06	1.64e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—CAT—coronary artery disease	2.11e-06	1.62e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—TGFB1—coronary artery disease	2.09e-06	1.6e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—APOB—coronary artery disease	2.05e-06	1.57e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—MAPK1—coronary artery disease	2.04e-06	1.57e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—GSTM1—coronary artery disease	1.99e-06	1.53e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—LPL—coronary artery disease	1.96e-06	1.5e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—GPX1—coronary artery disease	1.91e-06	1.47e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—CD36—coronary artery disease	1.86e-06	1.43e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—PPP2CA—coronary artery disease	1.84e-06	1.41e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—PIK3CA—coronary artery disease	1.77e-06	1.36e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—MTHFR—coronary artery disease	1.76e-06	1.35e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—AGT—coronary artery disease	1.67e-06	1.29e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—APOE—coronary artery disease	1.64e-06	1.26e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—APOA1—coronary artery disease	1.62e-06	1.25e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—IL6—coronary artery disease	1.57e-06	1.21e-05	CbGpPWpGaD
Fulvestrant—ESR1—Signaling Pathways—AKT1—coronary artery disease	1.45e-06	1.11e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—PPARG—coronary artery disease	1.43e-06	1.1e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—POMC—coronary artery disease	1.41e-06	1.08e-05	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—ALB—coronary artery disease	1.29e-06	9.87e-06	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—NOS3—coronary artery disease	1.23e-06	9.44e-06	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—PTGS2—coronary artery disease	1.12e-06	8.63e-06	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—PIK3CA—coronary artery disease	6.92e-07	5.31e-06	CbGpPWpGaD
Fulvestrant—CYP3A4—Metabolism—AKT1—coronary artery disease	5.65e-07	4.34e-06	CbGpPWpGaD
